We were able to observe that only a few out of the broad range of suggested pathway abnormalities critically affected the pathway’s behavior significantly to cause constitutive activation of PI3K-Akt and NF-κB in prostate cancer. This evidence concerns the gene AKT1 and prostate cancer.